Menopause Matters Forum

Menopause Discussion => All things menopause => Topic started by: dahliagirl on January 10, 2019, 10:51:53 AM

Title: Womans Hour Thursday 10 January
Post by: dahliagirl on January 10, 2019, 10:51:53 AM

https://www.bbc.co.uk/programmes/m0001ycp

We discuss new research that suggests there may be lower risks associated with HRT patches and gels and talk about how women and their GPs should weigh up the risks and benefits.

Missed it!  I am waiting for the catch up to catch up ….  ::)

Title: Re: Womans Hour Thursday 10 January
Post by: dahliagirl on January 10, 2019, 10:54:53 AM

Pah!!  It is up on the website now but won't work  :-\

Title: Re: Womans Hour Thursday 10 January
Post by: Night_Owl on January 10, 2019, 12:25:23 PM

Dahliagirl, Thanks for posting this.

A few things jumped out at me:

"80% of women take tablet HRT" 
"Don't recommend women take it for life"

At c.03:26, Dr Jarvis mentions mentions using Dydrogesterone (progesterone) as a form of 'natural progesterone' in the context of using patches?  Dydrogesterone (Duphaston) is discontinued in the UK and only available as *tablet form* Femoston.  What do you think she means.  Please can somebody point out what I've missed here.

Title: Re: Womans Hour Thursday 10 January
Post by: dahliagirl on January 10, 2019, 01:24:03 PM

I found that confusing too  >:(

The only combined patch at the moment seems to be Evorel which is Norithisterone.

Like you say, there is no separate dydrogesterone.


Most CCG seem to have a formulary that tells GPs to prescribe Elleste first (cheapest) and transdermal is only available if there is a problem with the tablet form (not so cheap), so that is probably why 80% take tablets.